Seddon Annika, Hock Barry, Miller Andrew, Frei Lukas, Pearson John, McKenzie Judith, Simcock Jeremy, Currie Margaret
Mackenzie Cancer Research Group, University of Otago Christchurch, PO Box 4345,Christchurch 8011, New Zealand; Centre for Free Radical Research, University of Otago Christchurch, PO Box 4345,Christchurch 8011, New Zealand.
Haematology Research Group, University of Otago Christchurch, PO Box 4345,Christchurch 8011, New Zealand.
J Dermatol Sci. 2016 Aug;83(2):124-30. doi: 10.1016/j.jdermsci.2016.04.013. Epub 2016 Apr 26.
A subset of presenting cutaneous squamous cell carcinomas (CSCC) is high risk with respect to their high rates of recurrence, metastasis and patient death. The identification of such high risk CSCC is problematic. Neutrophil and granulocytic myeloid derived suppressor cell (G-MDSC) numbers are elevated in a number of cancers, but their association with current markers of high risk tumors in the setting of CSCC is unknown.
To assess circulating and tumor-localised neutrophil and G-MDSC populations for associations with high-risk tumor characteristics and overall survival (OS) in CSCC patients.
A retrospective clinical audit was performed of patients who had hospital operations for primary CSCC and did not have other malignancies or HIV. Therapeutically immuno-suppressed individuals (TII, n=129) and non-TII (n=29) were analysed separately with respect to the presence of high-risk tumor features and OS. In addition, 47 patients with prospectively collected blood and primary CSCC tumor samples were analysed to determine frequencies of circulating G-MDSC and tumor localised CD66b+ and CD8+ leukocytes.
In the clinical audit of non-TII, high circulating neutrophil counts were associated with tumor thickness≥5mm, Clark level V and high T-stage. Univariate analysis showed elevated neutrophil count was a significant marker of poor OS, whilst tumor thickness remained the only independent histological predictor of OS after adjusting for age and immuno-suppression. The prospective study demonstrated that tumors≥5mm thick had significantly increased total and peri-tumorally localised CD66b+ leukocytes (comprising neutrophils and/or G-MDSC) and that elevated circulating G-MDSC numbers were associated with high T-stage tumors.
This study demonstrates that the presence of high risk CSCC is associated with increased numbers of both circulating and tumor resident populations of neutrophils and/or G-MDSC. These cell types therefore merit further investigation with respect to their functional and prognostic significance in CSCC.
一部分皮肤鳞状细胞癌(CSCC)具有高复发率、转移率及患者死亡率,属于高风险类型。识别这类高风险CSCC存在困难。中性粒细胞和粒细胞来源的髓系抑制细胞(G-MDSC)数量在多种癌症中升高,但在CSCC背景下它们与高风险肿瘤当前标志物的关联尚不清楚。
评估CSCC患者循环及肿瘤局部的中性粒细胞和G-MDSC群体与高风险肿瘤特征及总生存期(OS)的关联。
对因原发性CSCC接受手术且无其他恶性肿瘤或HIV的患者进行回顾性临床审计。分别分析免疫治疗抑制个体(TII,n = 129)和非TII个体(n = 29)的高风险肿瘤特征及OS情况。此外,对47例前瞻性采集血液和原发性CSCC肿瘤样本的患者进行分析,以确定循环G-MDSC以及肿瘤局部CD66b +和CD8 +白细胞的频率。
在非TII的临床审计中,循环中性粒细胞计数高与肿瘤厚度≥5mm、Clark分级V级及高T分期相关。单因素分析显示中性粒细胞计数升高是OS不良的显著标志物,而在调整年龄和免疫抑制因素后,肿瘤厚度仍然是OS的唯一独立组织学预测指标。前瞻性研究表明,厚度≥5mm的肿瘤中,总的及肿瘤周围局部CD66b +白细胞(包括中性粒细胞和/或G-MDSC)显著增加,且循环G-MDSC数量升高与高T分期肿瘤相关。
本研究表明,高风险CSCC的存在与循环及肿瘤局部的中性粒细胞和/或G-MDSC数量增加有关。因此,就这些细胞类型在CSCC中的功能和预后意义而言,值得进一步研究。